Shares of Hikma Pharmaceuticals PLC HIK inched up 0.33% to £18.37 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.65% to ...

Shares of Hikma Pharmaceuticals PLC HIK rallied 1.64% to £18.01 Thursday, on what proved to be an all-around poor trading ...

The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading.

The biggest fallers on the FTSE 100 were Schroders, down 49.8p to 313.8p, AstraZeneca, down 928p to 10,114p, Hikma ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

After holding firm till around mid afternoon on Wednesday, European stocks pared gains and closed weak as investors assessed the ...

United Kingdom equities were lower at the close on Tuesday, as losses in the FTSE 350 Pharmaceuticals & Biotechnology, FTSE ...

AstraZeneca PLC (LON:AZN) declined 8.40% or 928.00 points to end at 10,114.00 and Hikma Pharmaceuticals PLC (LON:HIK) was ...

Schizophrenia significantly shortens life expectancy by an estimated 15 years with excess mortality arising from multiple ...

Global Alcoholic Hepatitis Treatment MarketAccording to a recent analysis by Future Market Insights (FMI), the global ...

Read full market research report, Opioids Market Size, Share, and Growth Overview by 2031, published by The Insight Partners. Read full market research report, Opioids Market Size, Share, and Growth ...